Largest real-world study demonstrates significant survival advantage
Category: News
ISM001-055 shows promise in improving lung function among patients
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe
New government scheme to offer routine opt-out blood tests
£3m programme to accelerate new antimicrobial treatment
International think tanks to shape future of cancer research funding
International trial marks leap forward in chemotherapy-induced neuropathy care
There is currently no national screening programme for the disease in the UK
It is hoped that the tool will improve the diagnostic pathway and free up radiologists’ time